When

Friday, February 25, 2022

8:45 AM-10:45 AM ET

WheRE

Live Webinar

faculty

Tracy I. George, MD
(Virtual Professor)

Professor of Pathology
University of Utah School of Medicine
President and Chief Medical Officer
ARUP Laboratories
Salt Lake City, Utah

Matthew J. Hamilton MD
Assistant Professor of Medicine
Harvard Medical School
Lead Gastroenterologist
Brigham and Women’s Hospital Mastocytosis Center
Boston, Massachusetts

Anne Maitland, MD, PhD
Assistant Clinical Professor, Icahn School of Medicine
Department of Medicine Allergy & Clinical Immunology
New York, New York
Immunologist, Chiari EDS Mast Cell Activation Disorders Center
Mount Sinai South Nassau
Oceanside, New York

Lawrence B. Schwartz, MD, PhD
Charles & Evelyn Thomas Professor of Medicine
Chair, Division of Rheumatology Allergy & Immunology
Virginia Commonwealth University
Richmond, Virginia

Please join us for a live stream of this Non-CME Educational Program during the American Academy of Allergy, Asthma & Immunology (AAAAI) 2022 Annual Meeting.

 

This program is not sponsored or programmed by the AAAAI.

Target Audience

Allergists/clinical immunologists, dermatologists, gastroenterologists, hematologists/oncologists, and other specialist clinicians who treat patients with nonadvanced systemic mastocytosis.

Program Description

This Interactive Exchange™ educational program focuses on the identification and management of patients with nonadvanced systemic mastocytosis (SM). The program will open with a brief video segment featuring a 3D animation detailing the pathophysiological drivers of SM and their implications for the development of targeted therapies. Dynamic discussions among a multidisciplinary panel of experts will address challenges in the diagnosis and classification of nonadvanced SM, highlight recent clinical trial data on emerging targeted therapies, and emphasize real-world strategies for the comprehensive management of nonadvanced SM. The program will conclude with an engaging case study discussion highlighting the various clinical presentations of nonadvanced SM along with expert advice for practical and effective disease management. Please join us for this informative and engaging session.

Learning Objectives

Upon completion of this activity, the participant should be better able to:

  • Describe clinically relevant pathophysiology in the development of systemic mastocytosis, including the effects of driver mutations on mast cell hyperactivation
  • Identify patients with nonadvanced systemic mastocytosis based on symptomatology and appropriate ancillary testing
  • Discuss the clinical profiles and trial evidence for current and emerging targeted treatment options in nonadvanced systemic mastocytosis
  • Tailor therapeutic regimens for patients with nonadvanced systemic mastocytosis based on symptoms, risk stratification, treatment responses, and appropriate consultations with other specialist clinicians

Agenda

12:00 PM ET Introductions
12:10 PM ET What Is the Latest on Systemic Mastocytosis Pathophysiology?
12:20 PM ET Meet the Professors Discussion on Systemic Mastocytosis
01:20 PM ET Choose-a-Case: Prerecorded Patient Examples of Systemic Mastocytosis
01:35 PM ET Question & Answer Session

 

 

 

This activity is provided by Integritas Communications.

This activity is supported by an independent educational grant from Blueprint Medicines Corporation.

This activity is endorsed by The Mast Cell Disease Society, Inc.

There is no registration fee for attending this program.

This live activity will not offer continuing medical education (CME) credit.

Register Now

attend event
Related events
APR
24
2024
Regional Meeting Series
1.00 CME/CE

BRIDGE HCV

Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV

Time: 12:30 PM-1:30 PM CT
Venue: Cahaba Medical Care - In-Person Event
Location: Birmingham, AL
Faculty: Ellen F. Eaton, MD, MSPH, FIDSA
MAY
01
2024
Regional Meeting Series
1.00 CME/CE

BRIDGE HCV

Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV

Time: 12:00 PM-1:00 PM CT
Venue: Mostellar Medical - In-Person Event
Location: Irvington, AL
Faculty: William S. Bradford, MD
MAY
08
2024
Regional Meeting Series
1.00 CME/CE

BRIDGE HCV

Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV

Time: 12:00 PM-1:00 PM CT
Venue: Mostellar Medical - In-Person Event
Location: Irvington, AL
Faculty: William S. Bradford, MD
MAY
15
2024
Expert Roundtable™ Live Meeting
0.00 CME

Tackling Chronic Inflammatory Airway Diseases

A Unified Picture of Disease Processes and Targeted Management

Time: 6:00 PM-8:00 PM CT
Venue: Hyatt Regency Chicago, Grand GH
Location: Chicago, IL
Faculty: Joseph K. Han, MD, FARS, FAAAAI, FAAOA; Amber U. Luong, MD, PhD, FACS; Anju T. Peters, MD, MSCI
MAY
15
2024
Expert Roundtable™ Live Stream
0.00 CME

Tackling Chronic Inflammatory Airway Diseases

A Unified Picture of Disease Processes and Targeted Management

Time: 6:30 PM-8:00 PM CT
Venue: Live Stream
Location: Live Stream
Faculty: Joseph K. Han, MD, FARS, FAAAAI, FAAOA; Amber U. Luong, MD, PhD, FACS; Anju T. Peters, MD, MSCI
MAY
20
2024
Live Meeting
1.50 CME/CE

An Expert Panel on Severe Asthma

From the Epithelium to Better Patient Outcomes

Time: 6:30 PM-8:00 PM PT
Venue: Hilton Bayfront San Diego - Indigo Ballroom CGDH
Location: Indigo Ballroom CGDH
Faculty: Njira Lucia Lugogo, MD, MS; Michael E. Wechsler, MD, MMSc; Geoffrey Chupp, MD
MAY
20
2024
Virtual Live Stream
1.50 CME/CE

An Expert Panel on Severe Asthma

From the Epithelium to Better Patient Outcomes

Time: 6:30 PM-8:00 PM PT
Venue: Live Stream
Location: Live Stream
Faculty: Geoffrey Chupp, MD; Njira Lucia Lugogo, MD, MS; Michael E. Wechsler, MD, MMSc
available resources
meeting slides
interactive presentation
linked resources
Suggested Reading
Interactive Exchange

Is It Systemic Mastocytosis?

Best Practices for Diagnosis and Management